ALK-mutated non-small-cell lung cancer: a new strategy for cancer treatment.

Lung
Luis Cabezón-GutiérrezMaría Castro-Otero

Abstract

The anaplastic lymphoma kinase (ALK) tyrosine kinase (TK) receptor has emerged recently as a potentially relevant biomarker and therapeutic target in solid and hematologic tumors. A variety of alterations in the ALK gene, such as mutations, overexpression, amplification, translocations, or other structural rearrangements, have been implicated in human cancer tumorigenesis. In this article we review the potential role that ALK may have in lung tumor origin, the methodology to detect the different molecular alterations, and the most important clinical aspects of ALK alterations in NSCLC patients.

References

Mar 30, 2001·The Journal of Biological Chemistry·G E StoicaA Wellstein
Jul 18, 2002·The Journal of Biological Chemistry·Gerald E StoicaAnton Wellstein
Apr 20, 2004·Journal of Cellular Physiology·K PulfordF Turturro
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaPaul A Bunn
May 17, 2005·Nature Medicine·Roberto ChiarleGiorgio Inghirami
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Monika KasprzyckaMariusz A Wasik
Dec 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Anna V GalkinMarkus Warmuth
Aug 19, 2007·Medicinal Research Reviews·Rongshi Li, Stephan W Morris
Dec 12, 2007·The Journal of Biological Chemistry·Carmen J TartariCarlo Gambacorti-Passerini
Feb 5, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kazuya ShinmuraHaruhiko Sugimura
Mar 6, 2008·Neoplasia : an International Journal for Oncology Research·Sven PernerMark A Rubin
Apr 17, 2008·British Journal of Cancer·Y FukuyoshiM Mori
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jussi P KoivunenPasi A Jänne
Oct 17, 2008·Nature·Isabelle Janoueix-LeroseyOlivier Delattre
Mar 12, 2009·Expert Review of Anticancer Therapy·Thomas R WebbStephan W Morris
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kengo TakeuchiHiroyuki Mano
May 23, 2009·The Biochemical Journal·Ruth H PalmerBengt Hallberg
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott J RodigLucian R Chirieac
Sep 10, 2009·Molecular Cancer Research : MCR·Eva LinZora Modrusan
Mar 9, 2010·Haematologica·Katrien Van RoosbroeckIwona Wlodarska
May 11, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fergal C Kelleher, Ray McDermott
Jul 17, 2010·The Biochemical Journal·Christian C LeeGlen Spraggon
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Oct 29, 2010·The New England Journal of Medicine·Young Lim ChoiUNKNOWN ALK Lung Cancer Study Group
Nov 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marta SalidoEdurne Arriola
Mar 9, 2011·Nature Medicine·Anton Wellstein, Jeffrey A Toretsky
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johannes M HeuckmannRoman K Thomas
Nov 16, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J de Castro-CarpeñoC Belda-Iniesta

❮ Previous
Next ❯

Citations

May 24, 2013·Archives of Pharmacal Research·Muhammad LatifSeong Hwan Kim
Oct 23, 2013·The American Journal of Surgical Pathology·Oluwole FadareJonathan L Hecht
Jan 28, 2014·Current Opinion in Oncology·József Tímár
Feb 14, 2014·Metallomics : Integrated Biometal Science·Carlos P HuangStephen B Howell
Oct 2, 2013·Annals of the American Thoracic Society·Lonny YarmusVidya Sathiyamoorthy
Feb 6, 2014·The Analyst·Kerstin GallerUte Neugebauer
Jan 21, 2014·Current Opinion in Oncology·Daniel C Christoph, Wilfried E E Eberhardt
Oct 18, 2013·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Marc RiquetFrançoise Le Pimpec-Barthes
Apr 25, 2014·Analytica Chimica Acta·Corrado Di NataleRosamaria Capuano
Jan 16, 2014·BMC Veterinary Research·Evan T MariottiGwendolen Lorch
Jul 3, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hiroaki NittaThomas M Grogan
Mar 5, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Matthias PreusserPeter Birner
Mar 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sebastian F SchoppmannPeter Birner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.